Yanhua Du Selected Research

HE 36

1/2021	Tandem bispecific antibody prevents pathogenic SHIVSF162P3CN infection and disease progression.
1/2018	Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhua Du Research Topics

Disease

7	Infections 07/2022 - 11/2010
7	Neoplasms (Cancer) 05/2022 - 07/2013
5	Carcinogenesis 05/2022 - 04/2017
4	Severe Fever with Thrombocytopenia Syndrome 07/2022 - 08/2015
3	Virus Diseases (Viral Diseases) 07/2022 - 01/2021
3	Ovarian Neoplasms (Ovarian Cancer) 05/2022 - 04/2017
3	Viremia 01/2021 - 01/2018
2	Neuroblastoma 01/2021 - 01/2019
2	Carcinoma (Carcinomatosis) 11/2019 - 04/2017
1	COVID-19 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Hydrocephalus (Hydrocephaly) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Disease Progression 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 08/2020
1	Movement Disorders (Movement Disorder) 01/2020
1	Nervous System Malformations (Nervous System Congenital Malformations) 01/2020
1	Zika Virus Infection 12/2019
1	Asymptomatic Infections 11/2019
1	Foodborne Diseases 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 04/2016
1	Lewis Lung Carcinoma 01/2016
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 04/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 02/2014
1	Human Influenza (Influenza) 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Vaccinia 01/2013
1	Malaria 11/2010

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 01/2021 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 07/2022 - 11/2019
3	Immunoglobulin M (IgM)IBA 07/2022 - 04/2014
3	Broadly Neutralizing AntibodiesIBA 01/2021 - 01/2013
3	Histones (Histone)IBA 01/2019 - 01/2013
2	Immunoglobulin G (IgG)IBA 07/2022 - 08/2015
2	Antiviral Agents (Antivirals)IBA 01/2022 - 12/2019
2	EnzymesIBA 01/2021 - 04/2017
2	HE 36IBA 01/2021 - 01/2018
2	AntibodiesIBA 11/2019 - 08/2015
2	Neutralizing AntibodiesIBA 01/2018 - 04/2014
1	Monoclonal AntibodiesIBA 07/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	CytokinesIBA 05/2022
1	CreatinineIBA 01/2022
1	Hexosaminidases (Hexosaminidase)IBA 01/2022
1	NitrogenIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	CateninsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2021
1	Inosine FDA Link 01/2021
1	UbiquitinIBA 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	6-methyladenineIBA 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	N-Myc Proto-Oncogene ProteinIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Vitamin D FDA LinkGeneric 01/2020
1	Ubiquitin-Specific ProteasesIBA 11/2019
1	Nucleosomes (Nucleosome)IBA 01/2019
1	ChromatinIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Sirtuin 2IBA 04/2017
1	Phosphotransferases (Kinase)IBA 04/2017
1	antineoplaston A10 (A 10)IBA 04/2016
1	afliberceptIBA 01/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016
1	Nucleocapsid ProteinsIBA 08/2015
1	polyoxypeptin AIBA 02/2014
1	AntigensIBA 07/2013
1	Hemagglutinins (Hemagglutinin)IBA 01/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Combined VaccinesIBA 11/2010
1	1-propyl-4-O-beta galactopyranosyl-alpha galactopyranosideIBA 11/2010

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2016
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 01/2022
1	Immunotherapy 01/2021